secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acadia Healthcare Company, Inc. (ACHC)
CIK:        0001520697
Form:       8-K
Filed at:   2022-05-03T23:59:59+00:00
Accession:  0001157523-22-000544
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia Healthcare Q1 revenue up 11.9% to $616.7M; reaffirms FY2022 guidance
---------------------------------------------------------------------------

- Revenue $616.7M (+11.9% YoY); same-facility revenue +8.6% on 6.2% higher revenue per patient day and 2.2% more patient days.
- Adjusted EBITDA $135.5M vs $119.5M YoY; net income $60.8M ($0.67 diluted EPS); adjusted EPS also $0.67.
- Affirms FY2022 guidance: revenue $2.55-2.60B, Adj. EBITDA $575-610M, adj. EPS $2.85-3.15.
- New CEO Chris Hunter notes strong start; added 28 beds in Q1, plans ~300 beds in 2022, six de novo CTCs and JV openings.
- Balance sheet: $140.4M cash, net leverage ~2.3x, $440M available on revolver; repaid $10M on credit facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520697/000115752322000544/0001157523-22-000544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520697/000115752322000544/a52706867.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-000544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer